Sunway Medical Centre pioneers genomic services

Sunway Medical Centre (SMC) has unveiled its Genomic Medicine Services at the newly expanded Health Screening Department, marking a breakthrough in Malaysian healthcare.

As the first hospital-based genomic facility within the Sunway Healthcare Group, it offers advanced testing to deliver personalised care, addressing chronic conditions and rare diseases that challenge the nation’s health system.

This launch integrates genomic science into clinical practice, providing earlier diagnoses and tailored treatments previously available only abroad.

For patients and families, Sunway Medical Centre’s initiative promises to shorten the often years-long diagnostic process, offering hope and precision in an evolving medical landscape.

It’s a step toward a future where care fits individual needs.

Sunway Medical Centre leads with genomics

Dr Khoo Chow Huat, Managing Director of Hospital & Healthcare Operations at Sunway Healthcare Group, highlighted the vision.

“We aim to anticipate illness, not just treat it,” he said. “

These services bring world-class precision medicine to Malaysians, aligning care with each patient’s unique profile.”

The services include whole exome sequencing, hereditary cancer screening, and rare disease diagnostics.

Sunway Medical Centre links these tests with its multidisciplinary team, turning genetic insights into practical treatment plans.

This approach tackles Malaysia’s dual health burdens—chronic diseases like diabetes and undiagnosed rare conditions.

Also, the facility serves both local and international patients.

“This expansion reflects our commitment to accessible, data-driven care,” Dr Khoo added.

It aims to reduce the “diagnostic odyssey,” where families face years of uncertainty over complex symptoms.

Next, liquid biopsy for cancer screening enhances early detection.

“Timely insights can transform patient outcomes,” Dr Khoo noted.

The service opens via physician referrals or self-enquiries, broadening its reach.

Finally, SMC’s ranking as Malaysia’s top hospital in 2025 by Newsweek underscores this leap.

The “Sunway Medical Centre genomic breakthrough” sets a new standard in patient management.

Targeting health gaps and seeking answers

Malaysia grapples with rising chronic conditions.

The National Health and Morbidity Survey reports one in six adults with diabetes and one in three with high blood pressure.

Rare diseases, often undetected, add pressure due to limited diagnostic tools.

Sunway Medical Centre addresses this gap.

Whole exome sequencing can pinpoint genetic causes, cutting diagnostic delays from years to weeks.

This innovation supports families seeking answers for unexplained illnesses.

Also, the centre’s role grows regionally.

As a quaternary hospital, SMC leverages its 2024 and 2025 Newsweek Top 250 Hospitals listing to lead genomic adoption.

“Sunway Medical Centre rare disease solutions” aim to elevate national healthcare standards.

Then, the focus extends beyond treatment.

By making genomic testing accessible, SMC supports broader health policy, ensuring more Malaysians benefit from advanced care.

Background data fuels this mission.

The hospital’s pioneering spirit, backed by its Health Screening Department, positions it to shape Malaysia’s medical future.

Sunway Medical Centre’s Genomic Medicine Services mark a healthcare milestone, tackling chronic and rare diseases with precision.

Open to all via consultations, this “Sunway Medical Centre genomic breakthrough” promises better outcomes.